Evidence map›Paper›PMID 36581343›Full record

ArticleCancer genomics & proteomics

Transcriptomic Network Analysis Using Exfoliative Cervical Cells Could Discriminate a Potential Risk of Progression to Cancer in HPV-related Cervical Lesions: A Pilot Study.

Nora Jee-Young Park, Yeseul Choi, Donghyeon Lee, Ji Young Park, Jong Mi Kim, Yoon Hee Lee, Dae Gy Hong, Gun Oh Chong, Hyung Soo Han

Open access · diamondAbstract read
In one paragraph

Article in Cancer genomics & proteomics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Nora Jee-Young ParkDepartment of Pathology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Yeseul ChoiDepartment of Biomedical Science, Graduate School, Kyungpook National University, Daegu, Republic of Korea.
Donghyeon LeeDepartment of Biomedical Science, Graduate School, Kyungpook National University, Daegu, Republic of Korea.
Ji Young ParkDepartment of Pathology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Jong Mi KimDepartment of Obstetrics and Gynecology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Yoon Hee LeeDepartment of Obstetrics and Gynecology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Dae Gy HongDepartment of Obstetrics and Gynecology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Gun Oh ChongClinical Omics Research Center, School of Medicine, Kyungpook National University, Daegu, Republic of Korea; gochong@knu.ac.kr.
Hyung Soo HanClinical Omics Research Center, School of Medicine, Kyungpook National University, Daegu, Republic of Korea; hshan@knu.ac.kr.
Kyungpook National University · KRKyungpook National University Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimCervical cancer is the fourth most common type of cancer in women worldwide and it is a major cause of cancer-related deaths in developing countries. Despite the marked reduction observed in the rates of the disease as a result of screening programs, it is necessary to develop robust biomarkers that can detect the neoplastic progression early in HPV-related cervical lesions. MATERIALS AND

methodsWe performed comparative mRNA sequencing from exfoliative cervical cytology samples from nine Korean women using the Illumina NovaSeq6000 platform. Each pathological tissue was matched to the corresponding cytological sample. The pathologic diagnosis was scrutinized with ancillary immunohistochemistry and was considered a confirmative (endpoint) diagnosis. The pathological diagnoses consisted of three cases of chronic cervicitis, 2 high-grade squamous intraepithelial lesions (HSILs), 2 squamous cell carcinomas in situ (CIS), and 2 invasive squamous cell carcinomas (SQCCs), respectively. Using bioinformatic analyses, differentially expressed genes (DEGs; fold change ≥1.5; p<0.05) were applied for Gene Ontology (GO), Gene Set Enrichment Analysis (GSEA), and protein-protein interaction (PPI) networks.

resultsFrom a total of 55,882 genes, 438 DEGs were pinpointed; 282 genes were up-regulated and 156 genes down-regulated. These transcriptomic profiles were clearly divided into neoplastic (HSIL, CIS, and SQCC; ≥HSILs) and non-neoplastic lesions. The up-regulated DEGs were HIF-1a, EDN1, PIK3R3, PPP1CA and AKR1C1. GO, GSEA, and PPI network analyses showed marked associations with metabolism, proteolysis, or proteoglycan process pathways in cervical carcinogenesis.

conclusionThe transcriptomic analysis using exfoliative cervical cells was more likely representative of its corresponding histopathological diagnosis, thus emphasizing its potential utility in clinical practice. This study provides comprehensive transcriptomic network analyses for robust biomarkers that might present a high potential risk of progression to cancer in the exfoliative cervical cytology; our findings support their clinical utility for improved cervical cancer screening.

Indexed as

Carcinoma, Squamous CellPapillomavirus InfectionsUterine Cervical DysplasiaUterine Cervical NeoplasmsEarly Detection of CancerFemaleHumansPapillomaviridaePhosphatidylinositol 3-KinasesPilot ProjectsTranscriptomePhosphatidylinositol 3-KinasesPIK3R3 protein, humanbiomarkercytologyHPVneoplasmprogressionswabtranscriptome

Identifiers

PMID36581343
PMCPMC9806671
OpenAlexW4313424288

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.